Hypomagnesemia News and Research

RSS
Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen announces the results for Phase 3 PRIME '203' trial of Vectibix

Amgen announces the results for Phase 3 PRIME '203' trial of Vectibix

Amgen announces Phase 3 results evaluating Vectibix in combination with FOLFIRI chemotherapy

Amgen announces Phase 3 results evaluating Vectibix in combination with FOLFIRI chemotherapy

Positive phase 3 uveitis trial results for voclosporin

Positive phase 3 uveitis trial results for voclosporin